RecruitingNot ApplicableNCT05683041

Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy


Sponsor

University Hospital, Ghent

Enrollment

30 participants

Start Date

Feb 22, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Clinical study on the prevention of intrauterine adhesions after laparoscopic or laparotomic myomectomy. Myomas are common in women of reproductive age and myomectomy can lead to intra-uterine adhesions, which can be detrimental to fertility. This study investigates whether the use of an intrauterine gel can prevent the development of these adhesions.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is testing methods to prevent scarring inside the uterus (called intrauterine adhesions) that can form after surgery to remove uterine fibroids (myomectomy). Scar tissue after surgery can affect fertility and uterine health, and this study aims to find better ways to reduce this risk. **You may be eligible if...** - You are between 18 and 45 years old - You have uterine fibroids requiring laparoscopic or open abdominal surgery (myomectomy) - You have no pre-existing scar tissue in the uterus, confirmed by a pre-surgical procedure (hysteroscopy) **You may NOT be eligible if...** - You are pregnant - Your myomectomy will be combined with a hysteroscopic (internal) procedure at the same time - You have endometritis (infection of the uterine lining) - You are already using another anti-adhesion method Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHyalobarrier

Hyalobarrier is a viscous, transparent gel and is used as a preventive measure for post-operative adhesions in the abdominal and uterine cavity.


Locations(1)

University Hospital Ghent

Ghent, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05683041


Related Trials